Tecentriq

Tecentriq (atezolizumab) is an immunotherapy drug used to treat certain types of cancer. It works by helping the immune system recognize and attack cancer cells more effectively. Specifically, Tecentriq blocks a protein called PD-L1, which cancers often use to hide from immune cells. By blocking PD-L1, Tecentriq enables immune cells to identify and destroy cancer cells. It is used for conditions like bladder, lung, and breast cancers, often in combination with other treatments. Tecentriq represents a targeted approach that boosts the body's natural defenses to fight cancer more effectively.